Rating History for CRISPR Therapeutics (CRSP) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for CRSP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/18/2025 Brian Cheng New Coverage Overweight
(N/A)		 70.00
(N/A)		 61.19
(47.78)		 -21.92% Details